• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

作者信息

Mathian Alexis, Mahevas Matthieu, Rohmer Julien, Roumier Mathilde, Cohen-Aubart Fleur, Amador-Borrero Blanca, Barrelet Audrey, Chauvet Cecile, Chazal Thibaud, Delahousse Michel, Devaux Mathilde, Euvrard Romain, Fadlallah Jehane, Florens Nans, Haroche Julien, Hié Miguel, Juillard Laurent, Lhote Raphael, Maillet Thibault, Richard-Colmant Gaelle, Palluy Jean Baptiste, Pha Micheline, Perard Laurent, Remy Philippe, Rivière Etienne, Sène Damien, Sève Pascal, Morélot-Panzini Capucine, Viallard Jean-François, Virot Jean-Simon, Benameur Neila, Zahr Noël, Yssel Hans, Godeau Bertrand, Amoura Zahir

机构信息

Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France

Assistance Publique-Hôpitaux de Paris, Hôpital Henri Mondor, Service de Médecine Interne, Paris, France.

出版信息

Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.

DOI:10.1136/annrheumdis-2020-217566
PMID:32332072
Abstract
摘要

相似文献

1
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
2
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.COVID-19 患者伴系统性红斑狼疮，SARS-CoV-2 RNA 阳性复发后成功康复：病例报告及文献复习。
Clin Rheumatol. 2020 Sep;39(9):2803-2810. doi: 10.1007/s10067-020-05230-0. Epub 2020 Jul 28.
3
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.2019年冠状病毒病大流行期间羟氯喹短缺对系统性红斑狼疮患者的潜在后果
J Rheumatol. 2020 Jun 1;47(6):787-790. doi: 10.3899/jrheum.200395. Epub 2020 Apr 8.
4
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.一组患有风湿性疾病的COVID-19患者的临床病程、严重程度和死亡率。
Ann Rheum Dis. 2020 Dec;79(12):1659-1661. doi: 10.1136/annrheumdis-2020-218054. Epub 2020 Jun 30.
5
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.接受羟氯喹和阿奇霉素治疗的新冠肺炎患者的QT间期。
Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-2.
6
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.氯喹和羟氯喹治疗新冠病毒疾病的潜力引发了系统性红斑狼疮患者对药物短缺的担忧。
Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.
7
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.系统性红斑狼疮患者基线使用羟氯喹并不排除感染SARS-CoV-2及发生重症新型冠状病毒肺炎。
Ann Rheum Dis. 2020 Oct;79(10):1386-1388. doi: 10.1136/annrheumdis-2020-217690. Epub 2020 May 7.
8
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2021 Mar;80(3):e33. doi: 10.1136/annrheumdis-2020-217827. Epub 2020 May 29.
9
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour .对Nikpour所著《17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程》的回复
Ann Rheum Dis. 2021 Mar;80(3):e34. doi: 10.1136/annrheumdis-2020-217875. Epub 2020 May 29.
10
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.2019 年冠状病毒病（COVID-19）在自身免疫和炎症性疾病中的表现：不良结局的临床特征。
Rheumatol Int. 2020 Oct;40(10):1593-1598. doi: 10.1007/s00296-020-04676-4. Epub 2020 Aug 13.

引用本文的文献

1
Exploring the complex relationship between systemic lupus erythematosus and coronavirus disease 2019: genetic insights and potential protective mechanisms.探索系统性红斑狼疮与2019冠状病毒病之间的复杂关系：遗传学见解与潜在保护机制。
J Glob Health. 2025 Jul 11;15:04191. doi: 10.7189/jogh.15.04191.
2
Frequency, characteristics and outcome of corona virus disease 2019 (COVID-19) infection in Iranian patients with rheumatic diseases.伊朗风湿性疾病患者中2019冠状病毒病（COVID-19）感染的频率、特征及结果
Egypt Rheumatol. 2022 Jun;44(3):209-213. doi: 10.1016/j.ejr.2021.12.002. Epub 2021 Dec 10.
3
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus.
系统性红斑狼疮患者对 BNT162b2 疫苗接种后先天和适应性免疫应答受损。
JCI Insight. 2024 Mar 8;9(5):e176556. doi: 10.1172/jci.insight.176556.
4
COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study.贝利尤单抗治疗的系统性红斑狼疮患者中的新型冠状病毒肺炎：一项回顾性临床研究。
Immunol Res. 2024 Jun;72(3):418-429. doi: 10.1007/s12026-023-09449-2. Epub 2023 Dec 22.
5
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.COVID-19 预后在系统性红斑狼疮与类风湿关节炎和脊柱关节炎中的比较：来自意大利风湿病学会的 CONTROL-19 研究的结果。
Lupus Sci Med. 2023 Oct;10(2). doi: 10.1136/lupus-2023-000945.
6
COVID-19 mRNA vaccine, but not a viral vector-based vaccine, promotes neutralizing anti-type I interferon autoantibody production in a small group of healthy individuals.COVID-19 mRNA 疫苗，但不是基于病毒载体的疫苗，会在一小部分健康个体中促进产生针对 I 型干扰素的中和自身抗体。
J Med Virol. 2023 Oct;95(10):e29137. doi: 10.1002/jmv.29137.
7
Systemic lupus erythematosus nephritis and COVID-19 disease.系统性红斑狼疮肾炎与 COVID-19 疾病。
Clin Rheumatol. 2023 Sep;42(9):2335-2340. doi: 10.1007/s10067-023-06634-4. Epub 2023 May 17.
8
Cross-sectional study of COVID-19 infection in patients with rheumatic diseases in a sample of a Damascene population, Syria.叙利亚大马士革人群样本中风湿病患者新冠病毒感染的横断面研究。
Ann Med Surg (Lond). 2023 Mar 14;85(4):689-693. doi: 10.1097/MS9.0000000000000274. eCollection 2023 Apr.
9
Systemic Lupus Erythematosus and Coronavirus Disease 2019.系统性红斑狼疮与2019冠状病毒病
Rheumatol Immunol Res. 2021 Apr 13;2(1):15-18. doi: 10.2478/rir-2021-0004. eCollection 2021 Mar.
10
A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与自身免疫性疾病的综述：有何关联？
Life (Basel). 2022 Nov 18;12(11):1918. doi: 10.3390/life12111918.